Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments

H Yanai, H Adachi, M Hakoshima, S Iida… - International journal of …, 2023 - mdpi.com
Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a chronic liver disease
that affects more than a quarter of the global population and whose prevalence is increasing …

Effect of natural polysaccharides on alcoholic liver disease: A review

S Li, X Zhou, R Chen, Q Zhang, Y Sun… - International Journal of …, 2023 - Elsevier
In this study, we systematically collected relevant literature in the past five years on the
intervention of natural polysaccharides in alcoholic liver disease (ALD) and reviewed the …

Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth

Z Dashti, Z Yousefi, P Kiani, M Taghizadeh, MH Maleki… - Metabolism, 2024 - Elsevier
The incidence of nonalcoholic fatty liver disease (NAFLD) is on the rise, mirroring a global
surge in diabetes and metabolic syndrome, as its major leading causes. NAFLD represents …

Programmed cell death and lipid metabolism of macrophages in NAFLD

Z Xiao, M Liu, F Yang, G Liu, J Liu, W Zhao… - Frontiers in …, 2023 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) has now become the leading chronic liver disease
worldwide with lifestyle changes. This may lead to NAFLD becoming the leading cause of …

Cellular heterogeneity and plasticity during NAFLD progression

HJ Park, J Choi, H Kim, DY Yang, TH An… - Frontiers in Molecular …, 2023 - frontiersin.org
Nonalcoholic fatty liver disease (NAFLD) is a progressive liver disease that can progress to
nonalcoholic steatohepatitis (NASH), NASH-related cirrhosis, and hepatocellular carcinoma …

[HTML][HTML] Multi-omics analysis reveals hepatic lipid metabolism profiles and serum lipid biomarkers upon indoor relevant VOC exposure

G Miao, Y Wang, B Wang, H Yu, J Liu, R Pan… - Environment …, 2023 - Elsevier
As a widespread indoor air pollutant, volatile organic compound (VOC) caused various
adverse health effects, especial the damage to liver, which has become a growing public …

[HTML][HTML] Association between statins types with incidence of liver cancer: an updated meta-analysis

X Zhang, D Lou, R Fu, F Wu, D Zheng… - Current medicinal …, 2023 - ncbi.nlm.nih.gov
Objective This study aimed to explore the effect of different types of statins on the incidence
of liver cancer. Methods Relevant articles were systematically retrieved from PubMed …

Activation of AMPK entails the protective effect of royal jelly against high-fat-diet-induced hyperglycemia, hyperlipidemia, and non-alcoholic fatty liver disease in rats

AH Felemban, GM Alshammari, AEGA Yagoub… - Nutrients, 2023 - mdpi.com
This study examined the mechanism underlying the protective effect of royal jelly (RJ)
against high-fat-diet (HFD)-mediated non-alcoholic liver disease (NAFLD) in rats. Adult male …

Tiaogan Jiejiu Tongluo Formula attenuated alcohol-induced chronic liver injury by regulating lipid metabolism in rats

C Fang, J Zhang, J Han, Y Lei, Z Cao, J Pan… - Journal of …, 2023 - Elsevier
Abstract Ethnopharmacological relevance Tiaogan Jiejiu Tongluo Formula (TJTF), a
traditional Chinese medicine formula, is modified from the well-known ancient prescription …

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis

T Guo, W Yan, X Cui, N Liu, X Wei, Y Sun, KX Fan… - Molecular …, 2023 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common
complications of type 2 diabetes mellitus (T2DM). The pathogenesis of NAFLD involves …